March 1, 2017

0 Comments

Advances in the Management of Multiple Myeloma

James R Berenson, MD,abc Tanya M Spektor, PhD,c and James Wang, MDab aInstitute for Myeloma and Bone Cancer Research; bJames R Berenson, MD, Inc; and cOncotherapeutics, West Hollywood, California Correspondence: James R Berenson, MD; jberenson@imbcr.org. Disclosures: Dr Berenson is a consultant for and receives honoraria and research funding from Takeda, Amgen, Jansen, Celgene, and Bristol-Meyers-Squibb. […]

Continue reading...

March 1, 2017

0 Comments

To Transplant or Not To Transplant in Multiple Myeloma

Clinical Advances in Hematology & Oncology Authors: James R. Berenson, MD, Claudia Andreu-Vieyra, PhD, Sergio Giralt, MD May 2014, Volume 12, Issue 5 High-dose therapy in combination with autologous stem cell transplantation (ASCT) has become the standard of care for younger multiple myeloma patients. Is ASCT still the best treatment for these patients in the […]

Continue reading...

May 24, 2016

0 Comments

I Have WHAT? An Interview With Patient Advocate Debra Berenson

Interview with Debra Berenson, myeloma patient advocate, wife of myeloma expert Dr. James Berenson, and author of the book, I HAVE WHAT?. Debra has collected stories, insights, and tools for and from patients and their families with myeloma and related diseases. The second half of the book  includes information and advice from doctors and other healthcare professionals who treat […]

Continue reading...

July 17, 2015

0 Comments

IMBCR Identifies New Treatments for Myeloma in 2015!

First, we have made much progress on our new protein marker called B-cell maturation antigen (BCMA) that was initially found in the blood of myeloma patients. The level of this single serum marker predicts patient’s long-term outcomes. It also correlates with how the patient is doing in that very low levels are associated with patients […]

Continue reading...

May 21, 2015

0 Comments

KIIS Cares Interview

What: Myeloma is a disease in your bone marrow. Inside your bone marrow are the cells that make your blood, your red cells, your white cells, and your platelets. This plays a key role in maintaining the strength of the bone. Why: There have been several recent breakthroughs for the treatment of multiple myeloma patients […]

Continue reading...

April 13, 2015

0 Comments

Counterpoints: Do Patients With Multiple Myeloma Need Maintenance Treatment?

By Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Multiple myeloma is an incurable disease, and patients who respond to treatment eventually relapse—which makes long-term maintenance therapy an appealing option. But is a treatment with an unclear effect on overall survival worth the side effects and financial cost? In this month’s […]

Continue reading...

February 6, 2015

0 Comments

Talking About Myeloma with Loved Ones

Do you feel the Love? The New Year is here. Perhaps you have been newly diagnosed? Whether a Myeloma warrior, or new to the world of MM, talking about the disease with loved ones can be difficult, at best. What is Multiple Myeloma anyway? It’s hard enough to understand the disease, let alone explain it! […]

Continue reading...

December 18, 2014

0 Comments

Updates on Treatment

Updates on Treatment

“How do you know if you are getting the right drugs at the right doses for treating your myeloma?”

Continue reading...

December 9, 2014

0 Comments

Year End 2014

The Institute has been involved in very exciting work this year. We have identified new treatments for myeloma, identified new ways to follow the disease and completed research that has led to a better understanding of the biology of myeloma. First, we have found that a drug named Jakafi, that is used to treat a […]

Continue reading...
Scroll Up